Pacific Biosciences of California, Inc.
PACB
$1.33
$0.064.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 279.51M | 298.65M | 314.74M | 343.11M | 389.93M |
| Total Receivables | 35.45M | 30.62M | 32.26M | 31.65M | 27.52M |
| Inventory | 49.29M | 53.15M | 53.84M | 54.01M | 58.76M |
| Prepaid Expenses | 10.79M | 11.51M | 12.27M | 15.47M | 18.78M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 20.00K | 300.00K | 300.00K | 690.00K | 690.00K |
| Total Current Assets | 375.05M | 394.24M | 413.40M | 444.92M | 495.68M |
|
|
|||||
| Total Current Assets | 375.05M | 394.24M | 413.40M | 444.92M | 495.68M |
| Net Property, Plant & Equipment | 65.84M | 64.71M | 66.61M | 69.20M | 46.60M |
| Long-term Investments | 317.76M | 317.76M | 317.76M | 317.76M | 317.76M |
| Goodwill | 317.76M | 317.76M | 317.76M | 317.76M | 317.76M |
| Total Other Intangibles | 15.12M | 16.14M | 17.16M | 18.18M | 389.57M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10.31M | 10.31M | 10.54M | 10.72M | 10.84M |
| Total Assets | 784.08M | 803.16M | 825.47M | 860.79M | 1.26B |
|
|
|||||
| Total Accounts Payable | 20.77M | 16.36M | 15.06M | 14.04M | 16.59M |
| Total Accrued Expenses | 26.98M | 23.62M | 20.85M | 23.48M | 21.51M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 448.00K | 3.62M | 3.70M | 5.42M | 10.03M |
| Total Finance Division Other Current Liabilities | 24.64M | 19.61M | 20.14M | 23.67M | 18.17M |
| Total Other Current Liabilities | 24.64M | 19.61M | 20.14M | 23.67M | 18.17M |
| Total Current Liabilities | 72.83M | 63.21M | 59.75M | 66.60M | 66.30M |
|
|
|||||
| Total Current Liabilities | 72.83M | 63.21M | 59.75M | 66.60M | 66.30M |
| Long-Term Debt | 645.38M | 645.16M | 646.44M | 646.21M | 647.49M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 56.59M | 54.30M | 52.08M | 50.48M | 14.91M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.93M | 4.40M | 5.71M | 5.86M | 25.15M |
| Total Liabilities | 778.73M | 767.07M | 763.98M | 769.15M | 753.85M |
|
|
|||||
| Common Stock & APIC | 2.70B | 2.69B | 2.68B | 2.67B | 2.66B |
| Retained Earnings | -2.70B | -2.65B | -2.62B | -2.58B | -2.15B |
| Treasury Stock & Other | 457.00K | 415.00K | 267.00K | 381.00K | 422.00K |
| Total Common Equity | 5.35M | 36.09M | 61.49M | 91.64M | 506.59M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.35M | 36.09M | 61.49M | 91.64M | 506.59M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.35M | 36.09M | 61.49M | 91.64M | 506.59M |
|
|
|||||